MBOT News and Press, Microbot Medical Inc. From 06/04/24

2024-06-04 06:20:00 ET 3 Reasons Why Risk Averse Investors Could Trade Penny Stocks Penny stocks often attract investors looking for substantial returns on small initial investments. Despite their reputation for high volatility, there are compelling reasons why even risk-averse traders ...

2024-06-04 05:43:55 ET Read the full article on Seeking Alpha For further details see: Microbot Medical stock dips on $2.35M equity offering

A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 17.9% to $0.1179 on volume of 290,472,504 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 7.1% to $0.6248 on volume of 223,394,331 shares GameStop Corporation (GME) rose 21.0% to $28...

Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...

BRAINTREE, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today reports that the first phase of the previously announced collaboration with Corewell Health has been completed, which de...

2024-04-15 08:52:53 ET More on Microbot Medical Microbot Medical announces settlement resolving legal matters Seeking Alpha’s Quant Rating on Microbot Medical Historical earnings data for Microbot Medical Financial information for Microbot Medical ...

All Regulatory, Clinical, Operational and Pre-Commercial Activities Continue to Stay on Track Despite the On-going Situation in Israel Company Believes that Both Regulatory and Commercial Milestones to be Achieved in Accordance with the Company’s Current Timeline BRAINTREE,...

2024-02-20 16:52:00 ET More on Microbot Medical Microbot Medical announces settlement resolving legal matters Microbot Medical down 22%, exercises investment options for $2.73M proceeds Read the full article on Seeking Alpha For further details see: Micro...

2024-02-05 12:11:35 ET More on Microbot Medical Microbot Medical announces settlement resolving legal matters Microbot Medical down 22%, exercises investment options for $2.73M proceeds Seeking Alpha’s Quant Rating on Microbot Medical Historical earnin...

BRAINTREE, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the LIBERTY ® Endovascular Robotic Surgical System, announced that it has filed an Investigational Device Exemption (IDE) application with the US Food and Drug Administration (FDA). The...